Literature DB >> 3958365

Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle.

D J Driscoll, G K Danielson, F J Puga, H V Schaff, C T Heise, B A Staats.   

Abstract

To determine the impact of the Fontan operation on exercise tolerance and on the cardiorespiratory response to exercise, we compared the results of graded exercise to maximal effort of 81 patients with tricuspid atresia or single functional ventricle studied preoperatively with those of 29 patients studied postoperatively. Postoperatively, the values for total work performed, duration of exercise and maximal oxygen uptake increased significantly. Regardless of operative status, the maximal heart rate during exercise was reduced. The cardiac output and stroke volume response to exercise were subnormal after operation. Systemic arterial blood oxygen saturation was reduced markedly preoperatively both at rest and during exercise; postoperatively, it was significantly greater than the preoperative value but it remained slightly abnormal. The ventilatory response to exercise (respiratory rate, minute ventilation and ventilatory equivalent for oxygen) decreased toward normal after operation. Exercise tolerance and the cardiorespiratory responses to exercise improve after the Fontan operation. Formal exercise testing is essential to quantitate the degree of improvement.

Entities:  

Mesh:

Year:  1986        PMID: 3958365     DOI: 10.1016/s0735-1097(86)80227-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  38 in total

Review 1.  Cardiac rehabilitation programmes in children.

Authors:  R L Washington
Journal:  Sports Med       Date:  1992-09       Impact factor: 11.136

2.  Restrictive ventilatory impairment and arterial oxygenation characterize rest and exercise ventilation in patients after fontan operation.

Authors:  H Ohuchi; H Ohashi; H Takasugi; O Yamada; T Yagihara; S Echigo
Journal:  Pediatr Cardiol       Date:  2004-05-12       Impact factor: 1.655

Review 3.  Hearts with one ventricle: current concepts and management.

Authors:  I D Sullivan; J F Taylor
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

Review 4.  Long-term results of the Fontan operation.

Authors:  D J Driscoll
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

5.  Exercise performance after surgery for pulmonary atresia and intact ventricular septum.

Authors:  Britt-Marie Ekman-Joelsson; Per M Gustafsson; Jan Sunnegårdh
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

6.  Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.

Authors:  Ari Cedars; Susan Joseph; Philip Ludbrook
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

7.  Effect of Fontan fenestration on regional venous oxygen saturation during exercise: further insights into Fontan fenestration closure.

Authors:  Rohit S Loomba; Michael E Danduran; Jennifer E Dixon; Rohit P Rao
Journal:  Pediatr Cardiol       Date:  2013-10-23       Impact factor: 1.655

8.  Effects of persistent Fontan fenestration patency on cardiopulmonary exercise testing variables.

Authors:  M Elisabeth Heal; Lanier B Jackson; Andrew M Atz; Ryan J Butts
Journal:  Congenit Heart Dis       Date:  2017-06-15       Impact factor: 2.007

9.  Computational modeling of pathophysiologic responses to exercise in Fontan patients.

Authors:  Ethan Kung; James C Perry; Christopher Davis; Francesco Migliavacca; Giancarlo Pennati; Alessandro Giardini; Tain-Yen Hsia; Alison Marsden
Journal:  Ann Biomed Eng       Date:  2014-09-27       Impact factor: 3.934

10.  Exercise capacity in the Bidirectional Glenn physiology: Coupling cardiac index, ventricular function and oxygen extraction ratio.

Authors:  Carolina Vallecilla; Reza H Khiabani; Phillip Trusty; Néstor Sandoval; Mark Fogel; Juan Carlos Briceño; Ajit P Yoganathan
Journal:  J Biomech       Date:  2015-04-06       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.